Cargando…
Precision medicine for Parkinson’s disease: The subtyping challenge
Despite many pharmacological and surgical treatments addressing the symptoms of Parkinson’s disease, there are no approved treatments that slow disease progression. Genetic discoveries in the last 20 years have increased our understanding of the molecular contributors to Parkinson’s pathophysiology,...
Autores principales: | Frasier, Mark, Fiske, Brian K., Sherer, Todd B. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9751632/ https://www.ncbi.nlm.nih.gov/pubmed/36533178 http://dx.doi.org/10.3389/fnagi.2022.1064057 |
Ejemplares similares
-
Mild Cognitive Impairment Subtypes Are Associated With Peculiar Gait Patterns in Parkinson’s Disease
por: Amboni, Marianna, et al.
Publicado: (2022) -
The future is precision medicine-guided diagnoses, preventions and treatments for neurodegenerative diseases
por: Rossi, Sharyn L., et al.
Publicado: (2023) -
A how-to guide for a precision medicine approach to the diagnosis and treatment of Alzheimer's disease
por: Devi, Gayatri
Publicado: (2023) -
Machine learning models for diagnosis and prognosis of Parkinson's disease using brain imaging: general overview, main challenges, and future directions
por: Garcia Santa Cruz, Beatriz, et al.
Publicado: (2023) -
Microglial autophagy in Alzheimer’s disease and Parkinson’s disease
por: Wang, Zhifu, et al.
Publicado: (2023)